WASHINGTON: Pfizer and BioNTech said on Tuesday they are seeking emergency authorization from US health regulators for the use of their COVID-19 vaccine for children over the age of six months and under the age of five.
If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it would become the first coronavirus vaccine available for this age group in the United States.
The companies said Tuesday that they have begun submitting their formal applications "after a request" from the FDA, which appears to want the process to proceed quickly.
In a tweet shortly after the announcement, the FDA said it would hold a meeting in two weeks on February 15 to consider the request.
"Providing a safe and effective vaccine for children in this age group is a priority for the agency," said FDA interim chief Janet Woodcock.
Pfizer CEO Albert Boerla said in a statement that the companies are seeking authorization for only two doses of their vaccine, but are confident that one is "to achieve a high level of protection against current and potential future variants". A third will be required.
"If two doses are authorized, parents will have the opportunity to start a COVID-19 vaccination series for their children while awaiting possible authorization of a third dose," he said.
To limit side effects for this young age group, Pfizer chose to reduce its vaccine dosage significantly, to just three micrograms per jab versus 30 for people over the age of 12, and from 10 to five. For 11 years old.
The company's researchers concluded last fall that a low dose of the vaccine provided protection in children up to two years of age, but not in children between the ages of two and five, and announced in December that they would be adding a third dose to their trials. .
Pfizer and BioNTech said in the statement that data on the three-dose regimen "is expected in the coming months and will be presented to the FDA to support potential expansion".
If the FDA authorizes emergency use of the vaccine, an advisory committee for the Centers for Disease Control and Prevention (CDC) will meet to decide whether or not to recommend its use.
slow movement in minors
There are nearly 23 million children under the age of five in the United States, and two years after the pandemic began, many parents are eagerly waiting to get their young children vaccinated against the coronavirus.
The Pfizer-BioEntech vaccine was approved three months ago for emergency use in children ages five to 11, but uptake has been relatively slow.
In that age group, only 30% have received at least one dose and about 22% have been fully vaccinated, according to the Centers for Disease Control and Prevention (CDC).
Young children are less likely to become seriously ill from COVID-19, but some still end up hospitalized by the virus.
The new pediatric coronavirus hospitalizations in the United States reached a record high in December as the Omicron strain spread rapidly.
Some cases of the deadly disease MIS-C (Multi-System Inflammatory Syndrome in Children) have also been reported in young children with COVID.
CDC data shows that nearly 400 children aged four and under have died of COVID-19 in the United States since the pandemic began.
- fda approval pfizer
- pfizer fda approved
- pfizer approved by fda
- fda pfizer approval
- us vaccine
- pfizer approved
- pfizer approval fda
- us vaccine approval
- us approved vaccines
- fda approval of vaccine
- 19 vaccine
- us approves vaccine
- pfizer age approval
- pfizer us
- pfizer is fda approved
- fda approval for pfizer
- fda approval of pfizer
- vaccines approved in us
- pfizer us vaccine
- vaccine 19
- pfizer age vaccine
- vaccine fda approval pfizer
- vaccine for under 5
- pfizer gets fda approval
- pfizer under 5
- pfizer us approval
- fda and pfizer
- pfizer approved vaccine
- us pfizer
- vaccine under 5
- vaccines approved in usa
- pfizer and fda approval
- vaccines that are fda approved
- fda to approve vaccine
- pfizer fda approval age
- pfizer pediatric vaccine
- vaccine approval news
- us fda vaccine approval
- vaccination approval
- new vaccine approval
- vaccines approved by the fda
- pfizer fda vaccine
- approved vaccines in us
- vaccine is fda approved
- approved vaccines in usa
- pfizer approved for what age
- approval of vaccine
- pfizer in us
- us fda pfizer
- pfizer approved age
- pfizer ages
- usa approved vaccines
- approved vaccines usa
- pfizer latest vaccine news
- pfizer is it fda approved
- approval vaccine
- pfizer approval us
- vaccines approved by us
- fda to approve pfizer
- vaccines approved by usa
- vaccine fda pfizer
- pfizer pediatric
- vaccine us approval
- vaccination fda
- age for pfizer
- vaccine age approval
- vaccine approval by fda
- pfizer fda approval vaccine
- which vaccine fda approved
- vaccine approved for 5 and up
- fda approval on vaccine
- pfizer about us
- pfizer to be fda approved
- pfizer 5
- vaccines are fda approved
- pfizer approval usa
- fda vaccine approval pfizer
- pfizer is approved
- us pfizer approval
- approval for vaccine
- us and vaccine
- us approved pfizer
- pfizer fda news